SPRC
SciSparc Ltd.
$11.44
-0.87%
$6.6M
No data for this timeframe.
Vol
Market Cap$6.6M
Cap SizeNano Cap
Insider Activity0B / 1S
Insider Net $-$4.6K
Reddit Sentiment67° Warm
SEC Reports2
Press Releases5
Recent Activity
Jun 4, 2026
SEC
SciSparc's majority-owned subsidiary NeuroThera Labs completed the acquisition of a ~54% interest in CliniQuantum Ltd.,
6-K — Impact 4/10
Jun 4, 2026
Press
SciSparc's majority-owned subsidiary NeuroThera closed its acquisition of a ~54% interest in CliniQuantum for ~CAD$9.5M
Impact 4/10
Jun 4, 2026
announcement
SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum
<p>TEL AVIV, Israel, June 04, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or
Jun 1, 2026
Insider
Shrem Itschak sold 462 shares
Director @ $10.00 ($4.6K)
May 29, 2026
SEC
SciSparc's subsidiary NeuroThera Labs received conditional TSX Venture Exchange approval for its acquisition of ~54% of
6-K — Impact 4/10
May 28, 2026
Press
SciSparc announced that its majority-owned subsidiary NeuroThera received conditional TSX approval for the acquisition o
Impact 4/10
Latest Reports
NEUTRAL
6-K
4/10
SciSparc's majority-owned subsidiary NeuroThera Labs completed the acquisition of a ~54% interest in CliniQuantum Ltd.,
Jun 4, 2026
NEUTRAL
Press
4/10
SciSparc's majority-owned subsidiary NeuroThera closed its acquisition of a ~54% interest in CliniQuantum for ~CAD$9.5M
Jun 4, 2026
NEUTRAL
6-K
4/10
SciSparc's subsidiary NeuroThera Labs received conditional TSX Venture Exchange approval for its acquisition of ~54% of
May 29, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 1, 2026 | Shrem Itschak | SELL | $4.6K |
Reddit Sentiment
67°
Warm
Bearish
Neutral
Bullish
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
1 unique insiders with 1 transactions. Net insider value: -$4.6K ($0.00 bought, $4.6K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Shrem Itschak | Director | SELL | 462 | $10.00 | $4.6K |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 4.0/10.
NEUTRAL
4/10
SciSparc's majority-owned subsidiary NeuroThera closed its acquisition of a ~54% interest in CliniQu
Jun 4, 2026
NEUTRAL
4/10
SciSparc announced that its majority-owned subsidiary NeuroThera received conditional TSX approval f
May 28, 2026
NEUTRAL
4/10
SciSparc Ltd. announced that NeuroThera Labs, in which it holds a 75% stake, has filed a patent appl
Mar 16, 2026
MIXED
5/10
SciSparc Ltd. announced that its majority-owned subsidiary, NeuroThera Labs, has advanced its collab
Mar 12, 2026
MIXED
6/10
SciSparc Ltd. (SPRC) announced that its majority-owned subsidiary, NeuroThera Labs, is acquiring 54.
Mar 10, 2026
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2024-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
67°
Warm
Bearish
Neutral
Bullish
2 mentions
2 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 1, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 30, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Jun 4, 2026
announcement
SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum
<p>TEL AVIV, Israel, June 04, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs
May 28, 2026
announcement
SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum
<p align="justify">TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that
Apr 23, 2026
short_interest
FTD: SPRC — 108,113 shares ($0.7M) failed to deliver
Settlement: 20260423, Price: $6.12, FTD Value: $661,651.56, SCISPARC LTD ORD SHS COM NEW 2
Apr 22, 2026
short_interest
FTD: SPRC — 203,841 shares ($1.2M) failed to deliver
Settlement: 20260422, Price: $5.99, FTD Value: $1,221,007.59, SCISPARC LTD ORD SHS COM NEW 2
Apr 21, 2026
short_volume
Short Volume: SPRC — 56.0% short (1.3M / 2.3M)
Short: 1,305,491 | Exempt: 5,418 | TRF Vol: 2,329,946 | Short Ratio: 56.0% | Off-exchange volume (dark pool + OTC)
Mar 16, 2026
announcement
SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy
<p align="justify">TEL AVIV, Israel, March 16, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced tha
Mar 12, 2026
announcement
SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
<p align="justify">TEL AVIV, Israel, March 12, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that
Mar 10, 2026
m_and_a
SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails
<p>TEL AVIV, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Lab